XML 39 R29.htm IDEA: XBRL DOCUMENT v3.19.2
Segment Information (Tables)
6 Months Ended
Jun. 30, 2019
Segment Reporting [Abstract]  
Schedule Of Information For The Company's Operating Segments
Information for the Company's reportable segments for the three months ended June 30, 2019 and 2018 are as follows:
 
Three Months Ended June 30, 2019
Consumer Operations
Drug Development
Corporate
Consolidated
Total revenue
$
164,705



$
164,705

Interest income, net
$


13,361

$
13,361

Income (loss) from operations
$
11,821

(29,294
)
(1,380,665
)
$
(1,398,138
)
Three Months Ended June 30, 2018
Consumer Operations
Drug Development
Corporate
Consolidated
Total revenue
$
245,502



$
245,502

Interest income, net
$


51,809

$
51,809

Loss from operations
$
(645,687
)
(6,170,488
)
(2,287,506
)
$
(9,103,681
)
 

Information for the Company's reportable segments for the six months ended June 30, 2019 and 2018 are as follows:
 
Six Months Ended June 30, 2019
Consumer Operations
Drug Development
Corporate
Consolidated
Total revenue
$
269,682



$
269,682

Interest income, net
$


26,574

$
26,574

Loss from operations
$
(41,287
)
(29,678
)
(3,570,816
)
$
(3,641,781
)
Six Months Ended June 30, 2018
Consumer Operations
Drug Development
Corporate
Consolidated
Total revenue
$
424,084



$
424,084

Interest income, net
$


111,402

$
111,402

Loss from operations
$
(1,902,993
)
(10,834,565
)
(4,648,943
)
$
(17,386,501
)